FDA official logo
GSRS logoPFDA official logo

ROLZAVOSORITIDE

UNII:8Y5K6WLC4Y
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:ROLZAVOSORITIDE
GSRS Full Record:

  • 3067191-26-5
  • C-type natriuretic peptide (CNP, CNP2, NPPC), L-prolylglycyl[C-terminal 37-peptide (CNP-37)] (1-39 in the real sequence), substituted at N<sup>6</sup> of the L-lysyl residue 27 with a (28S)-28,46-dicarboxy-3-(2-hydroxyethyl)-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-3,6,15,24,29-pentaazahexatetracontan-1-oyl group; S<sup>23</sup>,S<sup>39</sup> -cyclo{L-prolylglycyl-L-glutaminyl-L-α-glutamyl-L-histidyl-L-prolyl-L -asparaginyl-L-alanyl-L-arginyl-L-lysyl-L-tyrosyl-L-lysylglycyl- L-alanyl-L-asparaginyl-L-lysyl-L-lysylglycyl-L-leucyl-L-seryl-L-lysylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-leucyl-N<sup>6</sup>-[(28S)-28,46-dicarboxy-3-(2-hydroxyethyl)-7,16,25,30-tetraoxo-9,12,18,21-tetraoxa-3,6,15,24,29-pentaazahexatetracontan-1-oyl]-L-lysyl-L-leucyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-methionyl-L-serylglycyl-L-leucylglycyl-L-cysteine}
  • L-Cysteine, L-prolylglycyl-L-glutaminyl-L-α-glutamyl-L-histidyl-L-prolyl-L-asparaginyl-L-alanyl-L-arginyl-L-lysyl-L-tyrosyl-L-lysylglycyl-L-alanyl-L-asparaginyl-L-lysyl-L-lysylglycyl-L-leucyl-L-seryl-L-lysylglycyl-L-cysteinyl-L-phenylalanylglycyl-L-leucyl-N<sup>6</sup>-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[(2-aminoethyl)(2-hydroxyethyl)amino]acetyl]-L-lysyl-L-leucyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-seryl-L-methionyl-L-serylglycyl-L-leucylglycyl-, cyclic (23→39)-disulfide
  • Rolzavosoritide
  • rolzavosoritide [INN]



UNII - 8Y5K6WLC4Y | UNII Search Service